- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02115555
Advancing Diabetes Management in Adolescents Using Health Information Technology
The study will compare three treatment strategies to look at the best clinical outcomes.
The investigator hypothesizes that the combined approach of a health information technology program plus a conflict-management contract will lead to the best outcomes.
Study Overview
Status
Conditions
Detailed Description
This study will compare three strategies for enhancing adherence to diabetes care in our population. The study will look at which strategy results in the best short-term clinical outcomes for the population. Also, the study will look at patient satisfaction of contact with his/her health care team, quality of life, and family dynamics.
The three arms are:
- HIT (health information technology) aided approach
- Contracted conflict-management strategy
- Combination of the HIT-aided approach and the contracted conflict management strategy
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Indiana
-
Carmel, Indiana, United States, 46032
- Riley Children's Specialties
-
Indianapolis, Indiana, United States, 46202
- Riley Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Type 1 diabetes diagnosed for at least 6 months
- At least one or more parent/guardian who agrees to participate
Exclusion Criteria:
- Other chronic diseases with the exception of well-controlled asthma or treated thyroid disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: HIT-aided approach
Adolescents and their parents randomized to this arm will be oriented on a HIT system.
The system transmits self monitoring blood glucose self monitoring blood glucose data to a secure web portal.
The subject will receive messages from the HIT system on the meter based upon the Self Monitored Blood glucose tests.
|
Subjects randomized to this approach will be using the HIT-aided monitor.
|
Experimental: Contracted conflict management system
Adolescent-parent pairs will meet with a health educator to establish a behavioral contract that will set patient-centered self-management goals for the adolescent.
|
Subjects randomized to this arm will be using the behavioral contracted conflict management system.
|
Experimental: HIT plus contracted conflict management
Adolescents and their parents randomized to this arm will be oriented on a HIT system.
The system transmits self monitoring blood glucose data to a secure web portal.
The subject will receive messages from the HIT system on the meter based upon the tests.
In addition, adolescent-parent pairs will meet with a health educator to establish a behavioral contract that will set patient-centered self-management goals for the adolescent.
This arm combines arms 1 and 2.
|
Subjects randomized to this arm will use both the HIT-aided approach and the behavioral contract conflict management system.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycemic Control using HBA1C
Time Frame: Baseline, 3 months, and 6 months
|
Change in Glycemic Control
|
Baseline, 3 months, and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of self monitoring blood glucose measurement
Time Frame: Baseline, 3 months, 6 months
|
change in Self-monitoring blood glucose measurement
|
Baseline, 3 months, 6 months
|
Quality of Life
Time Frame: Baseline and 6 months
|
Change in Diabetes-specific quality of life measures will be measured by the Varney's Pediatric Quality of Life 3.0 Diabetes Module.
|
Baseline and 6 months
|
Family dynamics
Time Frame: Baseline and 6 months
|
Change in family dynamics measured by the Cornell Parent Behavior Description Scale and the Helping for Health Inventory.
|
Baseline and 6 months
|
Treatment Adherence Behaviors
Time Frame: Once per month for 6 months
|
Change in treatment adherence behaviors measured by the Self-Care Inventory with supplemental questions determined by the investigator.
|
Once per month for 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satisfaction
Time Frame: 3 month and 6 month
|
Patient and parent satisfaction with the intervention with questions determined by the investigator.
|
3 month and 6 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tamara Hannon, MD, Indiana University School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-04, IRB00000219
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Eledon PharmaceuticalsWithdrawnBrittle Type 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Rabin Medical CenterDreaMed DiabetesTerminated
Clinical Trials on HIT-aided approach
-
Chulalongkorn UniversityCompletedAllergic RhinitisThailand
-
Liverpool John Moores UniversityCompleted
-
McGill University Health Centre/Research Institute...CompletedPhysical Activity | Colorectal CancerCanada
-
Chang Gung Memorial HospitalCompleted
-
Göteborg UniversitySahlgrenska University Hospital, SwedenCompleted
-
University of AdelaideRoyal Adelaide Hospital; University of South AustraliaTerminatedInsulin ResistanceAustralia
-
Haukeland University HospitalRecruitingBipolar Disorder | Schizophrenia and Related DisordersNorway
-
University of Erlangen-Nürnberg Medical SchoolKlinikum NürnbergCompleted
-
University of NottinghamUniversity Hospitals of Derby and Burton NHS Foundation TrustCompletedColorectal Neoplasms | Exercise | Aged | Preoperative CareUnited Kingdom
-
University of NottinghamCompletedElderly | Prehabilitation | Interval Training | Pre Operative ExerciseUnited Kingdom